NextCure, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NextCure, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • NextCure, Inc. Return On Equity for the quarter ending June 30, 2024 was -57.6 %, a 31.8% decline year-over-year.
  • NextCure, Inc. annual Return On Equity for 2023 was -47 %, a 19.8% decline from 2022.
  • NextCure, Inc. annual Return On Equity for 2022 was -39.3 %, a 45% decline from 2021.
  • NextCure, Inc. annual Return On Equity for 2021 was -27.1 %, a 132% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -47 -7.76 -19.8% Jan 1, 2023 Dec 31, 2023
2022 -39.3 -12.2 -45% Jan 1, 2022 Dec 31, 2022
2021 -27.1 -15.4 -132% Jan 1, 2021 Dec 31, 2021
2020 -11.7 +10.2 +46.6% Jan 1, 2020 Dec 31, 2020
2019 -21.8 -82.2 -136% Jan 1, 2019 Dec 31, 2019
2018 60.3 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.